Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. DNA Vaccine - An Introduction

4. Drivers & Challenges
    4.1 Drivers
          4.1.1 Increasing Investment
          4.1.2 Advantages of DNA Vaccines over Traditional Vaccines
          4.1.3 Dramatic Increase in Chronic Disorders
          4.1.4 Strong DNA Vaccine Pipeline
          4.1.5 Technological Advancements
    4.2 Challenges
          4.2.1 Uncertainty in Regulatory System
          4.2.2 Lack of Awareness in Developing Countries
          4.2.3 Development Limited to Plasmid Vectors

5. DNA Vaccine Market Overview

6. DNA Vaccines Market by Geography
    6.1 North America
    6.2 Europe
    6.3 Asia Pacific

7. DNA Vaccine Market by Type
    7.1 Recombinant Protein Vaccines
          7.1.1 By Geography (North America, Europe, Asia Pacific)
    7.2 Genetic Vaccines
          7.2.1 By Geography (North America, Europe, Asia-Pacific)

8. DNA Vaccines Market by End User
    8.1 Human
    8.2 Animal

9. DNA Vaccines Market by Therapeutic Indication
    9.1 Infectious & Vector Borne Diseases
    9.2 Cancer

10. Pipeline Analysis

11. Trends
      11.1 Increasing Focus on Genetic Vaccine Development
       11.2 Expanding Applications Increasing Popularity of DNA Vaccines
        11.3 Partnerships Enhancing Genetic Vaccines Development

12. Company Profiles
      12.1 Novartis International AG
      12.2 Merck & Co., Inc
      12.3 GlaxoSmithKline plc.
      12.4 Sanofi
      12.5 Zoetis
      12.6 Green Cross Corporation
      12.7 Inovio Pharmaceuticals, Inc.
      12.8 Bharat Biotech
      12.9 Indian Immunologicals Ltd.
      12.10 Serum Institute of India Pvt. Ltd

13. Recommendations